150 related articles for article (PubMed ID: 17611713)
21. Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.
Huang J; Chen K; Gong W; Zhou Y; Le Y; Bian X; Wang JM
Cancer Lett; 2008 Aug; 267(2):254-61. PubMed ID: 18433988
[TBL] [Abstract][Full Text] [Related]
22. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Lucio-Eterovic AK; Piao Y; de Groot JF
Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
[TBL] [Abstract][Full Text] [Related]
23. Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1.
Yang Y; Liu Y; Yao X; Ping Y; Jiang T; Liu Q; Xu S; Huang J; Mou H; Gong W; Chen K; Bian X; Wang JM
Am J Pathol; 2011 Sep; 179(3):1504-12. PubMed ID: 21782780
[TBL] [Abstract][Full Text] [Related]
24. Expression and functional role of formyl peptide receptor in human bone marrow-derived mesenchymal stem cells.
Kim MK; Min do S; Park YJ; Kim JH; Ryu SH; Bae YS
FEBS Lett; 2007 May; 581(9):1917-22. PubMed ID: 17442310
[TBL] [Abstract][Full Text] [Related]
25. The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes.
Tao HY; Wu CF; Zhou Y; Gong WH; Zhang X; Iribarren P; Zhao YQ; Le YY; Wang JM
Cell Mol Immunol; 2004 Feb; 1(1):50-6. PubMed ID: 16212921
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
27. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma.
Chen H; Shen X; Guo C; Zhu H; Zhou L; Zhu Y; Wang H; Zheng Y; Huang L
Cancer Biother Radiopharm; 2010 Dec; 25(6):713-21. PubMed ID: 21204766
[TBL] [Abstract][Full Text] [Related]
28. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
[TBL] [Abstract][Full Text] [Related]
29. Normal cell surface expression and selective loss of functions resulting from Phe110 to Ser and Cys126 to Trp substitutions in the formyl peptide receptor.
Nanamori M; He R; Sang H; Ye RD
Immunol Invest; 2004 May; 33(2):193-212. PubMed ID: 15195697
[TBL] [Abstract][Full Text] [Related]
30. Silencing the formylpeptide receptor FPR by short-interfering RNA.
Le Y; Iribarren P; Zhou Y; Gong W; Hu J; Zhang X; Wang JM
Mol Pharmacol; 2004 Oct; 66(4):1022-8. PubMed ID: 15258259
[TBL] [Abstract][Full Text] [Related]
31. The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.
Ping YF; Yao XH; Chen JH; Liu H; Chen DL; Zhou XD; Wang JM; Bian XW
J Neurooncol; 2007 Aug; 84(1):21-9. PubMed ID: 17415525
[TBL] [Abstract][Full Text] [Related]
32. Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells.
Hu YH; Kong SQ; Kong HB; Wu JL; Chen Z
Chin Med J (Engl); 2012 Jun; 125(11):2025-31. PubMed ID: 22884072
[TBL] [Abstract][Full Text] [Related]
33. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma.
Xie TX; Xia Z; Zhang N; Gong W; Huang S
Oncol Rep; 2010 Mar; 23(3):725-32. PubMed ID: 20127012
[TBL] [Abstract][Full Text] [Related]
34. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
35. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.
Honda S; Campbell JJ; Andrew DP; Engelhardt B; Butcher BA; Warnock RA; Ye RD; Butcher EC
J Immunol; 1994 Apr; 152(8):4026-35. PubMed ID: 7511663
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and characterization of fMLF-mimicking AApeptides.
Hu Y; Cheng N; Wu H; Kang S; Ye RD; Cai J
Chembiochem; 2014 Nov; 15(16):2420-6. PubMed ID: 25224835
[TBL] [Abstract][Full Text] [Related]
38. C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma.
Liu X; Liu K; Qin J; Hao L; Li X; Liu Y; Zhang X; Liu X; Li P; Han S; Mao Z; Shen L
Int J Cancer; 2015 Jun; 136(11):2524-34. PubMed ID: 25382637
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
